Every Form 4 that Lifevantage Corporation (LFVN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow LFVN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LFVN filings page.
Lifevantage Corp (LFVN) reported that its Chief Financial Officer, Carl Aure, had 1,869 shares of common stock withheld or delivered on September 10, 2026 to pay the exercise price or related tax liability at a reported price of $6.37 per share. After this transaction, he held 156,495 shares directly, which include 2,810 shares purchased on August 31, 2026 under the Employee Stock Purchase Plan. No Rule 10b5-1 trading plan is reported for this transaction.
Lifevantage Corp (LFVN) reported that Chief Sales Officer Kristen Cunningham executed several transactions in the company’s common stock. On September 14, 2026, she sold 8,901 shares at a weighted average price of $6.18 per share, with individual trade prices ranging from $6.15 to $6.26. She also sold 100 shares at $6.41 on September 11, 2026, and on September 10, 2026, 2,254 shares were delivered or withheld for payment of exercise price or tax liability at $6.37 per share. No Rule 10b5-1 trading plan is reported for these transactions.
Moorehead Terrence reported acquisition or exercise transactions in this Form 4 filing.
Lifevantage Corp granted President and CEO Terrence Moorehead equity awards on August 6, 2026. He received 308,642 shares of common stock as a stock unit award that vests in three equal installments on August 6 of 2027, 2028, and 2029, subject to continued service. He was also granted 540,123 Performance Restricted Stock Units (PRSUs), each representing one share of common stock. These PRSUs vest only if specified financial performance targets are achieved over a three-year period from August 6, 2026 to August 6, 2029, with 10% vesting at each achievement date and an additional 10% vesting on the first anniversary of each such achievement date, contingent on continued service.
Lifevantage Corp Chief Financial Officer Aure Carl reported a tax-related share disposition on Common Stock. A total of 1,361 shares were used to satisfy tax obligations at a reference price of $6.25 per share. After this tax-withholding disposition, Carl directly holds 155,554 shares of Lifevantage common stock.
Lifevantage Corp Chief Sales Officer Kristen Cunningham reported a tax-withholding disposition of company stock tied to equity compensation. On the reported date, 1,717 shares of common stock were withheld at a price of $6.25 per share to cover tax obligations. After this transaction, she directly holds 131,417 shares of Lifevantage common stock, so her overall ownership remains substantial and the event appears routine and compensation-related rather than an open-market trade.
Lifevantage Corp General Counsel Alissa Neufeld reported a routine tax-related share disposition. On July 1, 2026, 1,342 shares of common stock were delivered at $6.25 per share to satisfy tax obligations, classified as a tax-withholding disposition rather than an open-market trade. Following this transaction, Neufeld directly holds 112,744 shares of Lifevantage common stock.
Lifevantage Corp director Darwin Lewis reported an open-market purchase of company stock. On this Form 4, he bought 705 shares of Common Stock at a price of $8.595 per share. Following this transaction, he directly owns 137,268 shares of Lifevantage Corp Common Stock.
Lifevantage Corp director Michael A. Beindorff reported an indirect open-market sale of 10,000 shares of common stock on June 3, 2026. The sale, executed by the Michael A. Beindorff Trust, had a weighted average price of $8.5459 per share, with trades ranging from $8.00 to $8.94.
Following the sale, the trust held 41,625 shares. The filing also shows additional indirect holdings of 5,500 shares held by his spouse and 126 shares held by his spouse as custodian for minor children, plus 27,570 shares held directly by Beindorff.
Lifevantage Corp General Counsel Alissa Neufeld reported a routine share withholding related to taxes. On April 1, 2026, 1,446 shares of Common Stock were disposed of at $4.20 per share as a tax-withholding disposition, not an open‑market sale. Following this transaction, she directly owns 114,086 shares of Lifevantage Common Stock.
Lifevantage Corp President and CEO Steven R. Fife reported a tax-related share disposition involving company common stock. On April 1, 2026, 8,180 shares were delivered at $4.20 per share to cover exercise price or tax obligations.
This transaction is classified as a tax-withholding disposition, not an open-market sale. After the adjustment, Fife directly holds 735,471 shares of Lifevantage common stock, indicating he retains a significant equity stake in the company following this routine administrative event.
Lifevantage Corp Chief Financial Officer Aure Carl reported a routine tax-related share transfer. On April 1, 2026, he disposed of 1,527 shares of common stock at an indicated value of $4.20 per share to cover tax obligations by delivering shares.
After this tax-withholding disposition, Carl directly holds 156,915 shares of Lifevantage common stock. Because the transaction was for tax payment rather than an open-market sale, it reflects compensation-related administration rather than an active decision to buy or sell shares in the market.
Lifevantage Corp chief sales officer Kristen Cunningham reported a small share disposition related to tax withholding. On a compensation-related transaction, 1,928 shares of common stock were withheld at $4.20 per share to cover tax obligations.
After this event, she continues to directly hold 133,134 shares of Lifevantage common stock.
Lifevantage Corp director Lewis Darwin reported an open-market purchase of common stock. On this transaction date, he bought 1,055 shares at $5.23 per share, increasing his direct holdings to 136,563 shares. This filing shows a modest increase in his personal investment in the company.
Lifevantage Corp director Dayton Judd reported open-market purchases of the company’s common stock. He bought 10,500 shares on March 2, 2026 at $4.53, 18,097 shares on February 27, 2026 at $4.63, and 4,600 shares on February 26, 2026 at $4.58, totaling 33,197 shares.
After these transactions, Judd directly owns 80,359 shares. The filing also shows 749,325 shares held indirectly through Sudbury Capital Fund, LP, an investment entity with which he is associated.
LifeVantage director Darwin Lewis bought 3,955 shares of company common stock in an open‑market transaction at a weighted average price of $5.2216 per share. After this purchase on February 9, 2026, he directly owns 135,508 LifeVantage shares.
Lifevantage Corp director Michael Beindorff reported gifting company stock to a family trust. On 11/25/2025, he transferred 7,819 shares of Lifevantage common stock in a transaction coded "G," which indicates a gift with a reported price of $0 per share.
After this transaction, he directly owned 27,570 shares and indirectly held 51,625 shares through the Michael A. Beindorff Trust, where he and his spouse are trustees. Additional indirect holdings include 126 shares held by his spouse as custodian for minor children and 5,500 shares held by his spouse.
LifeVantage Corp (LFVN) director Michael A. Beindorff reported a sale of company stock in a Form 4 filing. On 11/19/2025, a trust for which he and his spouse serve as trustees sold 12,607 shares of LifeVantage common stock at a weighted average price of $6.4198 per share, with individual trades executed between $6.39 and $6.48. After this transaction, he reported beneficial ownership of 43,806 shares held by the trust, 35,389 shares held directly, 126 shares held by his spouse as custodian for minor children, and 5,500 shares held by his spouse.
LifeVantage (LFVN) reported an insider equity grant. A director acquired 13,531 shares of common stock on 11/06/2025, reflected at $7.76 per share, which the filing notes equals the weighted average closing price over the ten trading days ending the day before the grant.
The grant will vest in a single installment on November 6, 2026, subject to the director’s continuous service. Following this grant, the director beneficially owns 23,999 shares, held directly.
LifeVantage (LFVN) reported a routine insider equity grant. Director Cynthia Latham acquired 13,531 shares of common stock on 11/06/2025 under the company’s outside director compensation program. The grant vests in a single installment on November 6, 2026, contingent on continuous service. The reported price of $7.76 reflects the weighted average closing price over the ten trading days preceding the grant date. Following this grant, her beneficial ownership stands at 64,879 shares, held directly.
Lifevantage (LFVN) reported a director equity grant. Director Raymond B. Greer acquired 13,531 shares of common stock on 11/06/2025 under the outside director compensation program at a price equal to the $7.76 weighted average closing price over the ten trading days ending the day before the grant.
The award will vest in a single installment on 11/06/2026, contingent on continued service. Following the grant, Greer beneficially owns 112,819 shares, held directly.
LifeVantage (LFVN) director Michael A. Beindorff reported insider activity on Form 4. On 11/06/2025, he received 13,531 shares under the outside director compensation program, scheduled to vest on November 6, 2026; the price shown is $7.76, equal to the weighted average closing price over the prior ten trading days. On 11/07/2025, he sold 1,000 shares at $7.33 (direct) and 35,000 shares at a weighted average $6.9215 (indirect via trust), with a portion sold to cover taxes from a restricted stock vesting. Following these transactions, holdings include 35,389 shares direct, 56,413 shares indirect via trust, 126 shares held by spouse as custodian for minor children, and 5,500 shares held by spouse.
LifeVantage (LFVN) director Dayton Judd reported an equity award on a Form 4. On 11/06/2025, he was granted 13,531 shares of common stock under the company’s outside director compensation program. These shares will vest in a single installment on November 6, 2026.
The filing lists a price of $7.76, described as the weighted average closing price for the ten trading days ending the day before the grant date. Following the transaction, Judd beneficially owns 47,162 shares directly and 749,325 shares indirectly through Sudbury Capital Fund, LP.
LifeVantage (LFVN) reported a routine insider equity award. Director Darwin Lewis acquired 13,531 shares of common stock on 11/06/2025 under the company’s outside director compensation program. The price reported was $7.76, defined as the weighted average closing price over the ten trading days ending the day before the grant.
These shares will vest in a single installment on November 6, 2026, contingent on continuous service. Following the grant, Lewis beneficially owns 130,748 shares, held directly.
Kristen Cunningham, Chief Sales Officer and director at Lifevantage Corp (LFVN), reported an insider sale on 10/01/2025. The filing shows she sold 1,720 shares of Lifevantage common stock at a price of $9.56 per share, leaving her with 136,986 shares owned directly. The Form 4 was signed by a power of attorney on 10/03/2025. This report discloses a routine officer sale and the resulting post-transaction ownership.
Alissa Neufeld, who identifies her role as General Counsel of Lifevantage Corp (LFVN), reported a sale of 1,283 shares of the company's common stock on 10/01/2025 at a reported price of $9.56 per share. After the transaction the filing shows Ms. Neufeld beneficially owns 116,977 shares. The Form 4 is signed and dated 10/03/2025, indicating timely disclosure under Section 16 reporting requirements.
On 10/01/2025 Steven R. Fife, who is listed as President and CEO and a Director of Lifevantage Corp (LFVN), reported a sale of 8,181 shares of the company's common stock at a price of $9.56 per share. After the reported transaction, Mr. Fife's beneficial ownership is listed as 752,820 shares. The Form 4 was signed by a power of attorney on 10/03/2025.
Lifevantage Corp insider Carl Aure, the company's Chief Financial Officer, reported a sale of 1,361 shares of Common Stock on 10/01/2025 at a price of $9.56 per share. The Form 4 shows 159,969 shares remained beneficially owned by Mr. Aure after the transaction. The filing was signed by Alissa Neufeld as Power of Attorney on 10/03/2025.
Julie Boyster, listed as the Chief Marketing Officer of Lifevantage Corp (LFVN), reported a sale of company common stock on 10/01/2025. The Form 4 shows she disposed of 1,835 shares at a price of $9.56 per share. After the transaction she beneficially owned 150,088 shares, held directly. The filing was signed by a power of attorney on 10/03/2025. The form is a standard Section 16 filing reporting insider changes in beneficial ownership and contains no additional remarks or derivative transactions.